• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BARD PERIPHERAL VASCULAR, INC. CONQUEST 40 PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BARD PERIPHERAL VASCULAR, INC. CONQUEST 40 PTA DILATATION CATHETER; PTA BALLOON DILATATION CATHETER Back to Search Results
Model Number CQF75104
Medical Device Problem Code Material Rupture (1546)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 11/12/2020
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
As the lot number for the device was provided, a review of the device history record is currently being performed.The return of the sample is pending.The investigation of the reported event is currently underway.(expiry date: 01/2023).
 
Event or Problem Description
It was reported that during an angioplasty procedure, the balloon of the device allegedly ruptured.There was no reported patient injury.
 
Event or Problem Description
It was reported that during an angioplasty procedure, the balloon of the device allegedly ruptured.There was no reported patient injury.
 
Additional Manufacturer Narrative
H10: manufacturing review: a manufacturing review was not required as this is the only complaint reported to date for this product and lot.Investigation summary: one conquest 40 pta dilatation catheter was returned for the evaluation.Visual evaluation was performed and noted that device appeared bloody , no any other anomalies noted.Performance evaluation was performed, gw lumen of the catheter was flushed using an in-house syringe and noted that water was able to successfully exit out of the distal tip.Then in-house presto inflation device was used to inflate the balloon and noted that water was exiting from the balloon at the proximal end of the balloon.Then fibers were removed and a longitudinal rupture was noted on the balloon from distal tip under magnification.Therefore, the investigation is confirmed for the reported balloon rupture, as longitudinal balloon rupture was noted during the microscopic evaluation.A definitive root cause for the balloon rupture could not be determined based upon the provided information.Labeling review: the review of the instructions for use, indications, warnings, precautions, cautions, possible complications, and contraindications showed that the product labeling is adequate.H10: d4 (expiry date: 01/2023), g3.H11: h6(method, result, conclusion).H11: section a through f ¿ the information provide by bd represents all the known information at this time.Despite good faith efforts to obtain additional information, the complainant/reporter was unable or unwilling to provide any further patient, product, or procedural details to bd.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CONQUEST 40 PTA DILATATION CATHETER
Common Device Name
PTA BALLOON DILATATION CATHETER
Manufacturer (Section D)
BARD PERIPHERAL VASCULAR, INC.
1625 w 3rd st.
tempe AZ 85281
MDR Report Key10982770
Report Number2020394-2020-20806
Device Sequence Number16954164
Product Code DQY
UDI-Device Identifier00801741060632
UDI-Public(01)00801741060632
Combination Product (Y/N)N
Initial Reporter CountryKS
PMA/510(K) Number
K120660
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type Manufacturer
Report Source company representative,foreig
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 03/31/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberCQF75104
Device Catalogue NumberCQF75104
Device Lot NumberREEP3440
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer12/08/2020
Initial Date Received by Manufacturer 11/13/2020
Supplement Date Received by Manufacturer04/01/2021
Initial Report FDA Received Date12/10/2020
Supplement Report FDA Received Date04/26/2021
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Outcome Attributed to Adverse Event Other;
-
-